Sourcing WHO-GMP Certified Generics: What International Buyers Should Verify

“WHO-GMP certified” is one of the most important quality signals in global pharmaceutical trade — but buyers should know how to verify it. Use this checklist before you commit to any supplier.

1. Confirm the certification belongs to the manufacturing facility

WHO-GMP is a manufacturing certification held by the factory that produces the medicine, not by a trading company. Always ask which facility manufactures each product and request that facility’s valid GMP certificate.

2. Request the core documents

• WHO-GMP certificate — current and covering the relevant dosage form.
• COPP — Certificate of Pharmaceutical Product, ideally in WHO format.
• COA — batch-specific Certificate of Analysis.
• Free Sale Certificate — confirming the product is marketed in the country of origin.

3. Check stability data for your climate zone

Products destined for hot, humid markets should carry stability data for Zone IVa/IVb. Ask for the stability summary.

4. Look for stringent-regulator alignment where relevant

For higher-tier tenders, facilities with EU-GMP, PIC/S or other stringent-regulator approvals add assurance. Learn more about the certifications behind our products.

5. Assess documentation responsiveness

A reliable partner provides documents quickly and completely. Slow or incomplete paperwork is a red flag for later registration and customs problems.

Source with confidence

Every product we export is sourced from WHO-GMP certified facilities and supplied with full documentation. Request a quote with your requirements.

Understanding Different GMP Standards Across Global Markets

When sourcing generic medicines internationally, understanding the nuances between various GMP standards is essential for regulatory compliance in your target market. Different regulatory authorities maintain distinct requirements, and selecting a supplier whose manufacturing partners hold the appropriate certifications can significantly streamline your import and distribution process.

EU-GMP Certification

European Union Good Manufacturing Practice standards represent some of the most stringent pharmaceutical manufacturing requirements globally. Manufacturing facilities certified to EU-GMP standards undergo rigorous inspections by European Medicines Agency (EMA) representatives or national competent authorities. For buyers targeting European markets or countries that recognize EU-GMP equivalence, this certification ensures compliance with detailed requirements covering premises, equipment, personnel qualification, quality control, and documentation practices. Many African, Middle Eastern, and Latin American regulators accept EU-GMP certification as evidence of manufacturing quality.

TGA Certification (Australia)

The Therapeutic Goods Administration of Australia maintains its own GMP code that aligns closely with PIC/S standards. TGA-certified facilities demonstrate compliance with Australian regulatory expectations, which are particularly relevant for buyers in the Asia-Pacific region. Several Southeast Asian countries recognize TGA certification when evaluating imported pharmaceuticals.

ANVISA Standards (Brazil)

Brazil's health regulatory agency, ANVISA, enforces specific GMP requirements for pharmaceutical imports. Manufacturing facilities exporting to Brazil must either hold ANVISA certification or undergo the agency's inspection process. For buyers serving Latin American markets, understanding ANVISA requirements is crucial, as several neighboring countries reference Brazilian regulatory standards in their own approval processes.

PIC/S Membership

The Pharmaceutical Inspection Co-operation Scheme represents a mutual recognition framework among participating regulatory authorities. Manufacturing facilities inspected by one PIC/S member authority are generally recognized by others, reducing duplicate inspections and facilitating international trade. When evaluating suppliers, verify whether their manufacturing partners operate in PIC/S member countries and hold relevant certifications. Explore our country-specific supply capabilities to understand which certifications apply to your target markets.

Red Flags When Evaluating Generic Medicine Suppliers

Identifying warning signs early in your supplier evaluation process protects your business from regulatory complications, quality issues, and supply chain disruptions. International pharmaceutical buyers should remain vigilant for these critical red flags:

Documentation Inconsistencies

Legitimate suppliers provide consistent, verifiable documentation across all communications. Be cautious of suppliers who cannot provide manufacturing facility names, addresses, and certification numbers. Discrepancies between quoted product specifications and Certificate of Analysis data indicate potential quality control problems. Any reluctance to share batch manufacturing records, stability studies, or regulatory approval documentation should raise immediate concerns.

Unrealistic Pricing or Availability Claims

While competitive pricing is expected in generic pharmaceuticals, prices significantly below market averages may indicate compromised quality, counterfeit products, or unauthorized manufacturing. Similarly, suppliers claiming immediate availability of all products in unlimited quantities likely lack genuine manufacturing relationships. Reputable suppliers acknowledge lead times for production scheduling, quality testing, and regulatory documentation preparation.

Lack of Regulatory Knowledge

Professional pharmaceutical exporters understand destination country requirements and proactively discuss regulatory compliance. Suppliers unfamiliar with Certificate of Pharmaceutical Product (COPP) requirements, import licensing procedures, or market-specific labeling regulations demonstrate insufficient experience in international pharmaceutical trade. Review our regulatory insights to understand what knowledgeable suppliers should discuss.

Absence of Quality Agreements

Established suppliers operate under formal quality agreements with their manufacturing partners, defining specifications, testing protocols, deviation management, and complaint handling procedures. Suppliers unable or unwilling to share quality agreement frameworks may lack proper manufacturing oversight.

Communication and Transparency Issues

Delayed responses, evasive answers about manufacturing locations, or reluctance to arrange facility audits indicate potential problems. Professional suppliers facilitate buyer due diligence, including virtual or in-person manufacturing site visits when requested.

Evaluating Stability Data and Its Critical Importance

Stability data represents one of the most important yet frequently overlooked aspects of generic medicine procurement. This documentation demonstrates how pharmaceutical products maintain their quality, safety, and efficacy throughout their shelf life under specified storage conditions.

What Stability Studies Reveal

Comprehensive stability studies track multiple parameters over time: active pharmaceutical ingredient (API) content, degradation products, physical appearance, dissolution rates, and microbiological quality. These studies are conducted under controlled temperature and humidity conditions that simulate real-world storage scenarios, including accelerated conditions that predict long-term stability.

Regulatory Requirements

Most regulatory authorities require stability data covering the proposed shelf life before granting marketing authorization. ICH guidelines (Q1A-Q1F) provide internationally recognized stability testing protocols. When evaluating suppliers, request stability data that follows ICH guidelines or your specific market's requirements. The data should cover at least the proposed shelf life duration, with testing intervals at 0, 3, 6, 9, 12, 18, 24, and 36 months as applicable.

Key Elements to Verify

Review stability protocols to confirm they include your target market's climatic zone. Zone IV countries (hot and humid) require more stringent stability demonstration than Zone II (temperate) markets. Verify that testing includes all critical quality attributes: assay, impurities, dissolution, water content, and physical characteristics. The manufacturing facility conducting stability studies should be the same facility producing your commercial batches.

Ongoing Stability Programs

Reputable manufacturers maintain ongoing stability programs, continuously testing retained samples from commercial batches. This commitment to post-market surveillance ensures consistent product quality and provides early warning of potential stability issues. Ask suppliers about their manufacturing partners' ongoing stability commitments and annual stability reporting practices.

Building a Robust Supplier Qualification Process

Developing a systematic supplier qualification process protects your business interests and ensures regulatory compliance across your supply chain. International pharmaceutical buyers should implement a structured approach that evaluates suppliers across multiple dimensions.

Initial Assessment Phase

Begin with desktop research verifying the supplier's legal registration, business history, and market reputation. Request corporate documentation including business licenses, export licenses, and professional memberships. Tuli Enterprise maintains memberships with PHARMEXCIL (Pharmaceuticals Export Promotion Council of India) and FPME (Federation of Pharma Manufacturers & Exporters), demonstrating commitment to industry standards and ethical business practices.

Technical Evaluation

Assess the supplier's technical capabilities by reviewing their manufacturing partnerships, quality management systems, and regulatory expertise. Request detailed information about manufacturing facilities, including certification status, inspection history, and production capacity. Evaluate the supplier's product portfolio against your requirements, examining therapeutic coverage and dosage form capabilities. Browse our comprehensive product catalogue and therapeutic categories to understand our supply capabilities.

Quality System Assessment

Examine the supplier's quality agreements with manufacturing partners, complaint handling procedures, product recall protocols, and deviation management systems. Request sample quality documents including Certificates of Analysis, batch manufacturing records, and validation summaries. Professional suppliers maintain documented quality systems that define responsibilities, processes, and performance metrics.

Regulatory Compliance Verification

Confirm the supplier's ability to provide market-specific regulatory documentation. This includes Certificates of Pharmaceutical Product (COPP), Certificates of Analysis (CoA), Free Sale Certificates (FSC), and Common Technical Document (CTD) dossiers when required. Verify their understanding of your destination country's import requirements, labeling regulations, and pharmacovigilance obligations.

Commercial Terms Evaluation

Assess pricing competitiveness, payment terms, minimum order quantities, and lead times. Evaluate the supplier's logistics capabilities, including packaging standards, cold chain management for temperature-sensitive products, and shipping documentation accuracy. Discuss contingency plans for supply disruptions and quality issues.

Audit and Continuous Monitoring

Where feasible, conduct on-site audits of the supplier's operations and manufacturing facilities. For ongoing relationships, establish key performance indicators (KPIs) covering delivery reliability, documentation accuracy, quality consistency, and responsiveness. Schedule periodic re-qualification reviews to ensure continued compliance with your standards.

Documentation Requirements for Market-Specific Regulators

Each destination market imposes unique documentation requirements for pharmaceutical imports. Understanding these requirements before initiating procurement prevents costly delays and regulatory complications.

Universal Documentation

Certain documents are required across virtually all markets. The Certificate of Pharmaceutical Product (COPP), issued by the exporting country's regulatory authority, confirms that products are authorized for marketing and that manufacturing facilities comply with GMP standards. Certificates of Analysis (CoA) provide batch-specific quality testing results, confirming compliance with pharmacopoeial specifications. Commercial invoices, packing lists, and bills of lading constitute essential trade documentation.

Market-Specific Requirements

Middle Eastern markets often require additional documentation including Free Sale Certificates, embassy attestation, and Arabic language labeling. Gulf Cooperation Council (GCC) countries may require specific certificate formats and Ministry of Health pre-approvals. African markets frequently request manufacturer authorization letters, product samples for testing, and retention samples. Latin American countries often mandate sanitary registrations, with some requiring local technical representatives. Asian markets vary significantly, with some requiring extensive dossier submissions and others accepting streamlined documentation for registered products.

Dossier Submissions

Many markets require Common Technical Document (CTD) format dossiers for product registration. These comprehensive submissions include administrative information, quality documentation, non-clinical and clinical data. Module 3 (Quality) typically represents the most substantial component for generic medicines, covering drug substance and drug product information, manufacturing processes, specifications, stability data, and analytical validation. Tuli Enterprise provides CTD dossier support through our manufacturing partners, facilitating your registration processes across diverse markets.

Ongoing Compliance Documentation

Beyond initial import documentation, maintain awareness of ongoing requirements including pharmacovigilance reporting, annual product quality reviews, and variation applications for manufacturing or specification changes. Some markets require periodic re-certification or updated stability data submissions.

Practical Buyer Verification Checklist

Use this comprehensive checklist when evaluating potential generic medicine suppliers:

Supplier Credentials

• Verify business registration and export licensing
• Confirm professional association memberships
• Check market reputation and references
• Assess years of experience in pharmaceutical export
• Evaluate geographic supply experience relevant to your markets

Manufacturing Partner Verification

• Obtain complete manufacturing facility details (name, address, contact)
• Verify GMP certifications appropriate for your target markets
• Review recent inspection reports and compliance history
• Confirm production capacity and technology capabilities
• Assess facility's experience with your required dosage forms

Product Quality Documentation

• Request product specifications and test methods
• Review Certificates of Analysis from recent batches
• Examine stability data covering proposed shelf life
• Verify pharmacopoeial compliance (USP, BP, EP, IP as applicable)
• Assess impurity profiles and degradation product data

Regulatory Documentation

• Confirm availability of COPP for your destination country
• Verify Free Sale Certificate provision capability
• Assess CTD dossier availability and completeness
• Review product labeling and artwork approval processes
• Confirm understanding of destination market requirements

Commercial Terms

• Compare pricing against market benchmarks
• Evaluate minimum order quantities and flexibility
• Assess lead times for production and documentation